University Of Southampton
Clinical trials sponsored by University Of Southampton, explained in plain language.
-
New drug targets genetic weakness in mesothelioma tumors
Disease control Not yet recruitingThis phase 2 trial tests a drug called BMS-986504 in 30 people with relapsed mesothelioma whose tumors have a specific genetic marker (MTAP deficiency). The drug aims to shrink tumors by blocking a protein cancer cells need to grow. Researchers will measure how many patients have…
Phase: PHASE2 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New decision aid aims to put frail hip fracture patients in the driver's seat
Knowledge-focused Not yet recruitingThis study aims to create a guide that helps frail older adults with hip fractures choose treatments based on what matters most to them, such as walking ability or independence, rather than just survival. Researchers will review existing studies, analyze NHS data, and interview p…
Sponsor: University of Southampton • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New study seeks to help PCD patients navigate fertility and pregnancy
Knowledge-focused Not yet recruitingThis study works with patients and healthcare professionals to create educational resources about fertility and pregnancy for people with Primary Ciliary Dyskinesia (PCD). The goal is to develop a patient-friendly guide and a toolkit for doctors. The study will involve 30 partici…
Phase: NA • Sponsor: University of Southampton • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC